DIE BEHANDLUNG DER DARMKRANKHEITEN MIT KARAYA BISMUTH. = LE TRAITEMENT DES MALADIES INTESTINALES PAR LE KARAYA BISMUTHHARTL K.1977; THERAPIEWOCHE; DTSCH.; DA. 1977; VOL. 27; NO 3; PP. 379-384 (3P.); BIBL. 10 REF.Article

STRONTIUMPHOSPHAT-CHROMAT (VI), SR₃(PO₄)₂.SRCRO₄, EINE DIMORPHE HOCHTEMPERATURVERBINDUNG = PHOSPHOCHROMATE (VI) DE STRONTIUM, SR₃(PO₄)₂.SRCRO₄, UN COMPOSE DIMORPHE HAUTE TEMPERATUREHARTL K; BRAUNGART R.1978; Z. NATURFORSCH., B; DEU; DA. 1978; VOL. 33; NO 8; PP. 954-955; ABS. ENG; BIBL. 4 REF.Article

STRONTIUMCHROMAT (V,VI), SR²,67)D'ALEMB. _0.33(CRO₄)¹,33)(CRO₄)⁰,67), EINE HOCHTEMPERATURPHASE MIT DEFEKT-BARIUMPHOSPHAT-STRUKTUR = CHROMATE (V,VI) DE STRONTIUM, SR²,67)D'ALEMB. ⁰,33)(CRO₄)¹,33)(CRO₄)⁰,67), UNE PHASE HAUTE TEMPERATURE AVEC STRUCTURE DE PHOSPHATE DE BARYUM NON STOECHIOMETRIQUEHARTL K; BRAUNGART R.1978; Z. NATURFORSCH., B; DEU; DA. 1978; VOL. 33; NO 8; PP. 952-953; ABS. ENG; BIBL. 6 REF.Article

Gesundheitsbezogene Lebensqualität, Körpererleben und Angst bei Brustkrebspatientinnen im Langzeitverlauf = Long-term quality of life, body image and anxiety in women after breast cancerHÄRTL, K; JANNI, W; KÄSTNER, R et al.Geburtshilfe und Frauenheilkunde. 2003, Vol 63, Num 5, pp 446-452, issn 0016-5751, 7 p.Article

Activity of the short-acting thromboxane receptor antagonist, SQ 30,741, in thrombolytic and vasospastic models in monkeysSCHUMACHER, W. A; HERAN, C.L; HARTL, K. S et al.The Journal of pharmacology and experimental therapeutics. 1990, Vol 253, Num 2, pp 841-846, issn 0022-3565Article

Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patientsHÄRTL, K; JANNI, W; KÄSTNER, R et al.Annals of oncology. 2003, Vol 14, Num 7, pp 1064-1071, issn 0923-7534, 8 p.Article

Development of potent thrombin receptor antagonist peptidesBERNATOWICZ, M. S; KLIMAS, C. E; HARTL, K. S et al.Journal of medicinal chemistry (Print). 1996, Vol 39, Num 25, pp 4879-4887, issn 0022-2623Article

Assesment of the biological activity of chemically immobilized rhBMP-2 on titanium surfaces in vivoVOGGENREITER, G; HARTL, K; ASSENMACHER, S et al.Materialwissenschaft und Werkstofftechnik. 2001, Vol 32, Num 12, pp 942-948, issn 0933-5137Article

Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheepMONTALESCOT, G; LOWENSTEIN, E; OGLETREE, M. L et al.Circulation (New York, N.Y.). 1990, Vol 82, Num 5, pp 1765-1777, issn 0009-7322Article

Isolation and identification of lysophosphatidylcholines as endogenous modulators of thromboxane receptorsPHILLIPSON, D. W; TYMIAK, A. A; TUTTLE, J. G et al.Journal of lipid mediators. 1993, Vol 7, Num 2, pp 155-167, issn 0921-8319Article

Nonprostanoid prostacyclin mimetics. IV: Derivatives of 2-[3-[2-(4,5-diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid substituted α to the oxazole ringMEANWELL, N. A; ROSENFELD, M. J; SEILER, S. M et al.Journal of medicinal chemistry (Print). 1993, Vol 36, Num 24, pp 3871-3883, issn 0022-2623Article

Non-prostanoid prostacyclin mimetics. VI: Derivatives of 2-[3-[2-(4,5-diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid modified β-to the oxazole ringMEANWELL, N. A; ROSENFELD, M. J; ZAVOICO, G. B et al.Drug design and discovery (Print). 1994, Vol 11, Num 1, pp 73-89, issn 1055-9612Article

Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552HARRIS, D. N; MICHEL, I. M; OGLETREE, M. L et al.The Journal of pharmacology and experimental therapeutics. 1992, Vol 261, Num 1, pp 131-137, issn 0022-3565Article

Nonprostanoid prostacyclin mimetics. V: Structure-activity relationships associated with [3-[4-(4,5-diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acidMEANWELL, N. A; ROMINE, J. L; FEDERICI, M. E et al.Journal of medicinal chemistry (Print). 1993, Vol 36, Num 24, pp 3884-3903, issn 0022-2623Article